About this episode

The episode discusses three medical papers with surprising findings related to health data, melanoma treatment, and clot risks associated with JAK.

Three papers, three plot twists: new HS data that underwhelm on paper, a transected melanoma that may not need a sentinel node, and a possible explanation for why JAK clot risk may depend on the disease.

Topics covered

• health data
• melanoma treatment
• JAK clot risk
• clinical research
• medical papers

Mentioned in this episode

Organizations: HS

Products: JAK

More episodes of Derms on Drugs

• Tregs, Tape, and Tresses · September 11, 2026 · 29 min
• Don’t Wait for the Tunnels · September 8, 2026 · 18 min
• Patch Me If You Can · September 4, 2026 · 30 min
• The Long and Short of Male Genital Disease · August 21, 2026 · 42 min
• Three Sheets to Tofa · August 14, 2026 · 33 min
• Creams, Screams, and Measles · August 7, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the Derms on Drugs podcast page.